NDC 63020-078

NINLARO

Ixazomib

NINLARO is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Millennium Pharmaceuticals, Inc.. The primary component is Ixazomib Citrate.

Product ID63020-078_36c4c203-9566-4851-863c-ab7b786e9af5
NDC63020-078
Product TypeHuman Prescription Drug
Proprietary NameNINLARO
Generic NameIxazomib
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2015-11-20
Marketing CategoryNDA / NDA
Application NumberNDA208462
Labeler NameMillennium Pharmaceuticals, Inc.
Substance NameIXAZOMIB CITRATE
Active Ingredient Strength2 mg/1
Pharm ClassesProteasome Inhibitor [EPC],Proteasome Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 63020-078-02

3 BLISTER PACK in 1 CARTON (63020-078-02) > 1 CAPSULE in 1 BLISTER PACK (63020-078-01)
Marketing Start Date2015-11-20
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 63020-078-01 [63020007801]

NINLARO CAPSULE
Marketing CategoryNDA
Application NumberNDA208462
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-11-20

NDC 63020-078-02 [63020007802]

NINLARO CAPSULE
Marketing CategoryNDA
Application NumberNDA208462
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-11-20

Drug Details

Active Ingredients

IngredientStrength
IXAZOMIB CITRATE2.3 mg/1

OpenFDA Data

SPL SET ID:fcef9088-ebab-4bd8-933f-c35f9c8bd50b
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1723763
  • 1723757
  • 1723765
  • 1723767
  • 1723772
  • 1723770
  • Pharmacological Class

    • Proteasome Inhibitor [EPC]
    • Proteasome Inhibitors [MoA]

    NDC Crossover Matching brand name "NINLARO" or generic name "Ixazomib"

    NDCBrand NameGeneric Name
    63020-078NINLAROixazomib
    63020-079NINLAROixazomib
    63020-080NINLAROixazomib
    63020-230NINLAROixazomib
    63020-390NINLAROixazomib
    63020-400NINLAROixazomib

    Trademark Results [NINLARO]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    NINLARO
    NINLARO
    85854620 4905454 Live/Registered
    Millennium Pharmaceuticals, Inc.
    2013-02-20

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.